<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002006'>Tumorigenesis</z:mp> is a complex multistep process involving not only genetic and epigenetic changes in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell but also selective supportive conditions of the deregulated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment </plain></SENT>
<SENT sid="1" pm="."><plain>One key compartment of the microenvironment is the vascular niche </plain></SENT>
<SENT sid="2" pm="."><plain>The role of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> but also in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> is now well established </plain></SENT>
<SENT sid="3" pm="."><plain>Research on <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in general, and vascular endothelial growth factor in particular, is a major focus in biomedicine and has led to the clinical approval of several antiangiogenic agents including thalidomide, bevacizumab, <z:chebi fb="0" ids="50924">sorafenib</z:chebi>, <z:chebi fb="0" ids="38940">sunitinib</z:chebi>, pazopanib, temesirolimus, and everolimus </plain></SENT>
<SENT sid="4" pm="."><plain>Indeed, antiangiogenic agents have significantly changed treatment strategies in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> (<z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:hpo ids='HP_0005584'>renal cell carcinoma</z:hpo>, and <z:hpo ids='HP_0003002'>breast cancer</z:hpo>) and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Here we illustrate important aspects in the interrelationship between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and the microenvironment leading to <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>, with focus on <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and summarize derived targeted therapies </plain></SENT>
</text></document>